Literature DB >> 10978890

T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines.

W W Agace1, J M Higgins, B Sadasivan, M B Brenner, C M Parker.   

Abstract

The epithelia are the avascular layers of cells that cover the environment-exposed surfaces of the body. It appears that T cells localize to selected sites in or adjacent to epithelia via the selective expression of adhesion molecules and chemokine receptors on T cells. These bind to counter-receptors and to chemokines expressed by epithelial cells. Recently, there has been an advance in our understanding of the interaction of the alpha(Ebeta7) integrin with its epithelial cell ligand, E-cadherin. In addition, a new adhesion molecule has been identified on non-intestinal epithelial cells, termed lymphocyte-endothelial-epithelial-cell adhesion molecule (LEEP-CAM). Finally, there have been advances in our understanding of the role of skin- or gut-epithelia-derived chemokines in regulating activated T cell homing to these sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978890     DOI: 10.1016/s0955-0674(00)00132-0

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  64 in total

1.  N-cadherin involvement in the heterotypic adherence of malignant T-cells to epithelia.

Authors:  Irwan T Makagiansar; Helena Yusuf-Makagiansar; Atsutoshi Ikesue; Anna M Calcagno; Joseph S Murray; Teruna J Siahaan
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

2.  Differential regulation of CD103 (αE integrin) expression in human dendritic cells by retinoic acid and Toll-like receptor ligands.

Authors:  Mandi M Roe; Steve Swain; T Andrew Sebrell; Marisa A Sewell; Madison M Collins; Brian A Perrino; Phillip D Smith; Lesley E Smythies; Diane Bimczok
Journal:  J Leukoc Biol       Date:  2017-01-13       Impact factor: 4.962

Review 3.  Microbial control of regulatory and effector T cell responses in the gut.

Authors:  Timothy Hand; Yasmine Belkaid
Journal:  Curr Opin Immunol       Date:  2010-02-18       Impact factor: 7.486

Review 4.  The unique surface molecules on intestinal intraepithelial lymphocytes: from tethering to recognizing.

Authors:  Yuan Qiu; Yang Yang; Hua Yang
Journal:  Dig Dis Sci       Date:  2013-11-19       Impact factor: 3.199

5.  Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition.

Authors:  Yili Li; Maike Hofmann; Qian Wang; Leslie Teng; Lukasz K Chlewicki; Hanspeter Pircher; Roy A Mariuzza
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

6.  Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer.

Authors:  T A Zikos; A D Donnenberg; R J Landreneau; J D Luketich; V S Donnenberg
Journal:  Cancer Immunol Immunother       Date:  2011-03-05       Impact factor: 6.968

7.  Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model.

Authors:  Thorsten Demberg; Venkatramanan Mohanram; David Venzon; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

8.  The influence of partial or total thymectomy during open heart surgery in infants on the immune function later in life.

Authors:  J H Eysteinsdottir; J Freysdottir; A Haraldsson; J Stefansdottir; I Skaftadottir; H Helgason; H M Ogmundsdottir
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Th2 responses elicited by nasal epithelial cells exposed to house dust mite extract.

Authors:  Seung-Heon Shin; Mi-Kyung Ye
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

10.  Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial Cells.

Authors:  Tsukasa Matsumoto; Michiyo Moriya; Hiroaki Kiyohara; Yoshiaki Tabuchi; Haruki Yamada
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.